Gemmus Pharma
San Francisco, US
Find your way into Gemmus Pharma
Sign up to see every warm intro you have to Gemmus Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gemmus Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CD
Christopher DunnExecutive
WG
William GuilfordExecutive
WH
William HolsteinExecutive
DF

Daryl FauldsChief Executive OfficerDaryl Faulds is an Executive Officer and Director at Gemmus Pharma with background in molecular biology, cell biology, and bioinformatics, with particular expertise in immunology and pulmonary diseases. He has drug discovery and project management experience across biologics and small molecules, including development work for USDA and FDA applications.
Board
MR
Marc RubinBoard director
LM
Larry MillerBoard director
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 1 round · 2014
▶$3.3MraisedJun 2014 · 22 investors · PharmaceuticalsRule 506(b)
▶$3.3MraisedJun 2014 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher DunnDirector
- Marc RubinDirector
- William GuilfordExecutive Officer, Director
- William HolsteinExecutive Officer
- Larry MillerDirector
- Daryl FauldsExecutive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gemmus Pharma raised?
- Gemmus Pharma has disclosed $3.3M raised across 1 round.
- Where is Gemmus Pharma headquartered?
- Gemmus Pharma is headquartered in San Francisco, US.